| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.971 | 0.002 | 0.975 | Aldehyde oxidase inhibitor | 0.975 0.001 DBMET00251 | DBMET00251 | |
| 0.853 | 0.004 | 0.863 | Aryl hydrocarbon receptor agonist | 0.863 0.004 DBMET00251 | DBMET00251 | |
| 0.851 | 0.004 | 0.891 | 12-Lipoxygenase inhibitor | 0.891 0.003 DBMET00251 | DBMET00251 | |
| 0.851 | 0.005 | 0.884 | 15-Lipoxygenase inhibitor | 0.884 0.004 DBMET00251 | DBMET00251 | |
| 0.812 | 0.01 | 0.834 | Caspase 9 stimulant | 0.834 0.007 DBMET00251 | DBMET00251 | |
| 0.79 | 0.002 | 0.79 | Aldehyde dehydrogenase inhibitor | 0.759 0.002 DBMET00251 | ||
| 0.777 | 0.005 | 0.818 | Antioxidant | 0.818 0.004 DBMET00251 | DBMET00251 | |
| 0.785 | 0.018 | 0.806 | Apoptosis agonist | 0.806 0.016 DBMET00251 | DBMET00251 | |
| 0.763 | 0.005 | 0.771 | Caspase 3 stimulant | 0.771 0.004 DBMET00251 | DBMET00251 | |
| 0.733 | 0.004 | 0.795 | MAO A inhibitor | 0.795 0.003 DBMET00251 | DBMET00251 | |
| 0.728 | 0.003 | 0.73 | NOS3 expression enhancer | 0.73 0.003 DBMET00251 | DBMET00251 | |
| 0.721 | 0.004 | 0.767 | MAO inhibitor | 0.767 0.004 DBMET00251 | DBMET00251 | |
| 0.714 | 0.004 | 0.714 | Breast cancer-resistant protein inhibitor | 0.708 0.004 DBMET00251 | ||
| 0.699 | 0.005 | 0.76 | Free radical scavenger | 0.76 0.004 DBMET00251 | DBMET00251 | |
| 0.697 | 0.005 | 0.773 | Lipoxygenase inhibitor | 0.773 0.004 DBMET00251 | DBMET00251 | |
| 0.677 | 0.004 | 0.735 | Monophenol monooxygenase inhibitor | 0.735 0.004 DBMET00251 | DBMET00251 | |
| 0.667 | 0.004 | 0.667 | GABA C receptor rho-3 antagonist | 0.622 0.005 DBMET00251 | ||
| 0.665 | 0.003 | 0.72 | Melanin inhibitor | 0.72 0.003 DBMET00251 | DBMET00251 | |
| 0.659 | 0.005 | 0.695 | Hypoxia-inducible factor 1 alpha inhibitor | 0.695 0.005 DBMET00251 | DBMET00251 | |
| 0.647 | 0.004 | 0.677 | Peroxidase inhibitor | 0.677 0.003 DBMET00251 | DBMET00251 | |
| 0.667 | 0.024 | 0.701 | Transcription factor NF kappa B inhibitor | 0.701 0.02 DBMET00251 | DBMET00251 | |
| 0.64 | 0.004 | 0.683 | MAO B inhibitor | 0.683 0.004 DBMET00251 | DBMET00251 | |
| 0.632 | 0.002 | 0.645 | Histidine decarboxylase inhibitor | 0.645 0.002 DBMET00251 | DBMET00251 | |
| 0.665 | 0.04 | 0.718 | Alpha-glucosidase inhibitor | 0.718 0.03 DBMET00251 | DBMET00251 | |
| 0.626 | 0.002 | 0.626 | CF transmembrane conductance regulator agonist | 0.546 0.002 DBMET00251 | ||
| 0.616 | 0.007 | 0.69 | Amyloid beta aggregation inhibitor | 0.69 0.005 DBMET00251 | DBMET00251 | |
| 0.609 | 0.004 | 0.656 | Amylase inhibitor | 0.656 0.003 DBMET00251 | DBMET00251 | |
| 0.583 | 0.004 | 0.633 | NADPH oxidase inhibitor | 0.633 0.003 DBMET00251 | DBMET00251 | |
| 0.583 | 0.005 | 0.591 | Topoisomerase II inhibitor | 0.591 0.005 DBMET00251 | DBMET00251 | |
| 0.584 | 0.012 | 0.625 | Histamine release inhibitor | 0.625 0.008 DBMET00251 | DBMET00251 | |
| 0.573 | 0.003 | 0.65 | Cystathionine beta-synthase inhibitor | 0.65 0.003 DBMET00251 | DBMET00251 | |
| 0.571 | 0.005 | 0.604 | Pyruvate kinase inhibitor | 0.604 0.004 DBMET00251 | DBMET00251 | |
| 0.603 | 0.053 | 0.638 | Antiinflammatory | 0.638 0.044 DBMET00251 | DBMET00251 | |
| 0.541 | 0.003 | 0.607 | Estrogen receptor alpha antagonist | 0.607 0.003 DBMET00251 | DBMET00251 | |
| 0.529 | 0.004 | 0.529 | Estrogen receptor beta antagonist | 0.518 0.004 DBMET00251 | ||
| 0.527 | 0.004 | 0.592 | Xanthine oxidase inhibitor | 0.592 0.003 DBMET00251 | DBMET00251 | |
| 0.519 | 0.003 | 0.519 | Interleukin 5 antagonist | 0.45 0.003 DBMET00251 | ||
| 0.525 | 0.017 | 0.544 | Apoptosis antagonist | 0.544 0.015 DBMET00251 | DBMET00251 | |
| 0.508 | 0.004 | 0.508 | Estrogen antagonist | 0.502 0.004 DBMET00251 | ||
| 0.505 | 0.003 | 0.515 | Alcohol dehydrogenase inhibitor | 0.515 0.003 DBMET00251 | DBMET00251 | |
| 0.509 | 0.014 | 0.514 | Vasodilator, coronary | 0.514 0.014 DBMET00251 | DBMET00251 | |
| 0.517 | 0.027 | 0.517 | 5 Hydroxytryptamine release inhibitor | 0.483 0.038 DBMET00251 | ||
| 0.523 | 0.037 | 0.539 | Prostaglandin dehydrogenase inhibitor | 0.539 0.034 DBMET00251 | DBMET00251 | |
| 0.5 | 0.016 | 0.532 | Nitric oxide antagonist | 0.532 0.014 DBMET00251 | DBMET00251 | |
| 0.488 | 0.016 | 0.494 | Hypoglycemic | 0.494 0.016 DBMET00251 | DBMET00251 | |
| 0.477 | 0.006 | 0.477 | Bone formation stimulant | 0.464 0.007 DBMET00251 | ||
| 0.465 | 0.001 | 0.514 | DOPA decarboxylase inhibitor | 0.514 0.001 DBMET00251 | DBMET00251 | |
| 0.454 | 0.003 | 0.539 | Macrophage migration inhibitory factor inhibitor | 0.539 0.003 DBMET00251 | DBMET00251 | |
| 0.459 | 0.009 | 0.474 | Hepatoprotectant | 0.474 0.008 DBMET00251 | DBMET00251 | |
| 0.444 | 0.004 | 0.444 | Estrogen agonist | 0.443 0.004 DBMET00251 | ||
| 0.479 | 0.047 | 0.486 | Antibacterial | 0.486 0.045 DBMET00251 | DBMET00251 | |
| 0.433 | 0.004 | 0.437 | Topoisomerase II alpha inhibitor | 0.437 0.004 DBMET00251 | DBMET00251 | |
| 0.431 | 0.004 | 0.497 | Beta glucuronidase inhibitor | 0.497 0.004 DBMET00251 | DBMET00251 | |
| 0.429 | 0.005 | 0.429 | Heat shock protein 90 alpha antagonist | 0.422 0.005 DBMET00251 | ||
| 0.435 | 0.015 | 0.446 | RNA-directed DNA polymerase inhibitor | 0.446 0.014 DBMET00251 | DBMET00251 | |
| 0.426 | 0.008 | 0.468 | Lipid peroxidase inhibitor | 0.468 0.006 DBMET00251 | DBMET00251 | |
| 0.427 | 0.013 | 0.432 | P-glycoprotein inhibitor | 0.432 0.013 DBMET00251 | DBMET00251 | |
| 0.416 | 0.003 | 0.425 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.425 0.003 DBMET00251 | DBMET00251 | |
| 0.401 | 0.003 | 0.448 | Creatine kinase inhibitor | 0.448 0.002 DBMET00251 | DBMET00251 | |
| 0.424 | 0.027 | 0.424 | Interleukin antagonist | 0.411 0.029 DBMET00251 | ||
| 0.419 | 0.036 | 0.458 | Spasmolytic | 0.458 0.029 DBMET00251 | DBMET00251 | |
| 0.408 | 0.027 | 0.441 | DNA damaging | 0.441 0.021 DBMET00251 | DBMET00251 | |
| 0.382 | 0.003 | 0.382 | Papain-like protease (SARS coronavirus) inhibitor | 0.373 0.003 DBMET00251 | ||
| 0.404 | 0.026 | 0.446 | Tumour necrosis factor alpha release inhibitor | 0.446 0.02 DBMET00251 | DBMET00251 | |
| 0.386 | 0.009 | 0.396 | Protein-tyrosine phosphatase inhibitor | 0.396 0.009 DBMET00251 | DBMET00251 | |
| 0.387 | 0.012 | 0.427 | Mcl-1 antagonist | 0.427 0.009 DBMET00251 | DBMET00251 | |
| 0.377 | 0.008 | 0.394 | Acetylcholinesterase inhibitor | 0.394 0.007 DBMET00251 | DBMET00251 | |
| 0.373 | 0.005 | 0.377 | Heat shock protein 90 antagonist | 0.377 0.005 DBMET00251 | DBMET00251 | |
| 0.369 | 0.008 | 0.369 | Amyloid beta precursor protein antagonist | 0.367 0.008 DBMET00251 | ||
| 0.389 | 0.03 | 0.457 | Antiamyloidogenic | 0.457 0.02 DBMET00251 | DBMET00251 | |
| 0.4 | 0.047 | 0.4 | Streptokinase A inhibitor | 0.368 0.056 DBMET00251 | ||
| 0.366 | 0.019 | 0.366 | Dual specificity phosphatase inhibitor | 0.366 0.019 DBMET00251 | ||
| 0.354 | 0.012 | 0.364 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.364 0.011 DBMET00251 | DBMET00251 | |
| 0.369 | 0.028 | 0.374 | Angiogenesis stimulant | 0.374 0.027 DBMET00251 | DBMET00251 | |
| 0.344 | 0.008 | 0.382 | Alkaline phosphatase inhibitor | 0.382 0.006 DBMET00251 | DBMET00251 | |
| 0.365 | 0.029 | 0.395 | Vasodilator | 0.395 0.024 DBMET00251 | DBMET00251 | |
| 0.361 | 0.034 | 0.407 | Superoxide dismutase inhibitor | 0.407 0.025 DBMET00251 | DBMET00251 | |
| 0.334 | 0.009 | 0.362 | Chelator | 0.362 0.007 DBMET00251 | DBMET00251 | |
| 0.384 | 0.063 | 0.384 | Thioredoxin glutathione reductase inhibitor | 0.372 0.068 DBMET00251 | ||
| 0.327 | 0.009 | 0.337 | Protein-tyrosine phosphatase 1B inhibitor | 0.337 0.008 DBMET00251 | DBMET00251 | |
| 0.322 | 0.007 | 0.357 | Interleukin 4 antagonist | 0.357 0.005 DBMET00251 | DBMET00251 | |
| 0.325 | 0.015 | 0.337 | Cholinergic | 0.337 0.014 DBMET00251 | DBMET00251 | |
| 0.312 | 0.003 | 0.34 | Fatty acid synthase inhibitor | 0.34 0.003 DBMET00251 | DBMET00251 | |
| 0.315 | 0.009 | 0.354 | 5-Lipoxygenase inhibitor | 0.354 0.007 DBMET00251 | DBMET00251 | |
| 0.298 | 0.003 | 0.351 | Estradiol 17 beta-dehydrogenase inhibitor | 0.351 0.003 DBMET00251 | DBMET00251 | |
| 0.29 | 0.004 | 0.29 | Estrogen receptor beta agonist | 0.287 0.004 DBMET00251 | ||
| 0.297 | 0.011 | 0.323 | Topoisomerase I inhibitor | 0.323 0.009 DBMET00251 | DBMET00251 | |
| 0.293 | 0.012 | 0.307 | Succinate dehydrogenase inhibitor | 0.307 0.01 DBMET00251 | DBMET00251 | |
| 0.288 | 0.006 | 0.288 | GABA C receptor rho-2 antagonist | 0.264 0.009 DBMET00251 | ||
| 0.292 | 0.012 | 0.292 | Hexokinase inhibitor | 0.261 0.015 DBMET00251 | ||
| 0.306 | 0.027 | 0.314 | MAP-kinase-activated kinase 5 inhibitor | 0.314 0.023 DBMET00251 | DBMET00251 | |
| 0.286 | 0.009 | 0.303 | Carbonic anhydrase XV inhibitor | 0.303 0.008 DBMET00251 | DBMET00251 | |
| 0.279 | 0.003 | 0.337 | Xanthine dehydrogenase inhibitor | 0.337 0.003 DBMET00251 | DBMET00251 | |
| 0.274 | 0.005 | 0.274 | Photosensitizer | 0.239 0.007 DBMET00251 | ||
| 0.296 | 0.028 | 0.331 | DNA methyltransferase I inhibitor | 0.331 0.017 DBMET00251 | DBMET00251 | |
| 0.279 | 0.018 | 0.298 | Nitric-oxide synthase stimulant | 0.298 0.012 DBMET00251 | DBMET00251 | |
| 0.269 | 0.007 | 0.3 | Carbonic anhydrase III inhibitor | 0.3 0.005 DBMET00251 | DBMET00251 | |
| 0.262 | 0.005 | 0.273 | Aldose reductase inhibitor | 0.273 0.005 DBMET00251 | DBMET00251 | |
| 0.266 | 0.01 | 0.266 | Antibacterial (Helicobacter pylori) | 0.261 0.01 DBMET00251 | ||
| 0.275 | 0.022 | 0.359 | Tubulin antagonist | 0.359 0.014 DBMET00251 | DBMET00251 | |
| 0.304 | 0.054 | 0.304 | Transcription factor STAT inhibitor | 0.299 0.056 DBMET00251 | ||
| 0.252 | 0.005 | 0.255 | Multidrug resistance-associated protein 1 inhibitor | 0.255 0.005 DBMET00251 | DBMET00251 | |
| 0.254 | 0.009 | 0.274 | Telomerase inhibitor | 0.274 0.008 DBMET00251 | DBMET00251 | |
| 0.249 | 0.005 | 0.249 | MAP kinase kinase 4 inhibitor | 0.239 0.006 DBMET00251 | ||
| 0.242 | 0.004 | 0.242 | Estrogen receptor alpha agonist | 0.238 0.004 DBMET00251 | ||
| 0.355 | 0.119 | 0.366 | Cyclophilin D inhibitor | 0.366 0.111 DBMET00251 | DBMET00251 | |
| 0.28 | 0.044 | 0.28 | Tyrosine 3 hydroxylase inhibitor | 0.276 0.047 DBMET00251 | ||
| 0.275 | 0.041 | 0.295 | Platelet adhesion inhibitor | 0.295 0.035 DBMET00251 | DBMET00251 | |
| 0.246 | 0.013 | 0.253 | Neurotrophic factor | 0.253 0.012 DBMET00251 | DBMET00251 | |
| 0.25 | 0.021 | 0.345 | M18 aspartyl aminopeptidase inhibitor | 0.345 0.008 DBMET00251 | DBMET00251 | |
| 0.268 | 0.039 | 0.306 | DNA methylase inhibitor | 0.306 0.026 DBMET00251 | DBMET00251 | |
| 0.23 | 0.009 | 0.237 | Uric acid excretion stimulant | 0.237 0.008 DBMET00251 | DBMET00251 | |
| 0.275 | 0.06 | 0.293 | 5 Hydroxytryptamine uptake stimulant | 0.293 0.048 DBMET00251 | DBMET00251 | |
| 0.353 | 0.138 | 0.389 | DNA polymerase beta inhibitor | 0.389 0.124 DBMET00251 | DBMET00251 | |
| 0.253 | 0.039 | 0.264 | Dual specificity phosphatase 3 inhibitor | 0.264 0.036 DBMET00251 | DBMET00251 | |
| 0.239 | 0.027 | 0.24 | Phospholipase C inhibitor | 0.24 0.027 DBMET00251 | DBMET00251 | |
| 0.269 | 0.059 | 0.314 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.314 0.046 DBMET00251 | DBMET00251 | |
| 0.216 | 0.008 | 0.245 | Aromatase inhibitor | 0.245 0.007 DBMET00251 | DBMET00251 | |
| 0.247 | 0.04 | 0.271 | Neurotrophic factor enhancer | 0.271 0.028 DBMET00251 | DBMET00251 | |
| 0.213 | 0.012 | 0.244 | Carbonic anhydrase VI inhibitor | 0.244 0.009 DBMET00251 | DBMET00251 | |
| 0.342 | 0.142 | 0.375 | DNA directed DNA polymerase inhibitor | 0.375 0.127 DBMET00251 | DBMET00251 | |
| 0.199 | 0.003 | 0.244 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.244 0.002 DBMET00251 | DBMET00251 | |
| 0.204 | 0.008 | 0.204 | DNA repair enzyme inhibitor | 0.197 0.009 DBMET00251 | ||
| 0.236 | 0.045 | 0.236 | I kappa B kinase epsilon inhibitor | 0.231 0.048 DBMET00251 | ||
| 0.208 | 0.018 | 0.208 | Interleukin 1b antagonist | 0.194 0.021 DBMET00251 | ||
| 0.262 | 0.074 | 0.262 | Transcription factor STAT3 inhibitor | 0.258 0.077 DBMET00251 | ||
| 0.198 | 0.011 | 0.235 | Protein kinase C zeta inhibitor | 0.235 0.008 DBMET00251 | DBMET00251 | |
| 0.248 | 0.065 | 0.289 | Cyclic AMP phosphodiesterase inhibitor | 0.289 0.046 DBMET00251 | DBMET00251 | |
| 0.204 | 0.022 | 0.225 | Toll-Like receptor 2 antagonist | 0.225 0.014 DBMET00251 | DBMET00251 | |
| 0.269 | 0.089 | 0.269 | Immunostimulant | 0.252 0.095 DBMET00251 | ||
| 0.187 | 0.01 | 0.267 | HIV-1 integrase (3'-Processing) inhibitor | 0.267 0.006 DBMET00251 | DBMET00251 | |
| 0.204 | 0.028 | 0.21 | Mannose-6-phosphate isomerase inhibitor | 0.21 0.025 DBMET00251 | DBMET00251 | |
| 0.19 | 0.015 | 0.221 | Carbonic anhydrase XIII inhibitor | 0.221 0.011 DBMET00251 | DBMET00251 | |
| 0.245 | 0.074 | 0.284 | Dyrk kinase inhibitor | 0.284 0.058 DBMET00251 | DBMET00251 | |
| 0.259 | 0.088 | 0.26 | Insulysin inhibitor | 0.26 0.088 DBMET00251 | DBMET00251 | |
| 0.192 | 0.023 | 0.212 | Butyrylcholinesterase inhibitor | 0.212 0.019 DBMET00251 | DBMET00251 | |
| 0.18 | 0.012 | 0.18 | GABA C receptor rho-1 antagonist | 0.156 0.019 DBMET00251 | ||
| 0.2 | 0.033 | 0.2 | Interleukin 1 antagonist | 0.199 0.033 DBMET00251 | ||
| 0.18 | 0.013 | 0.193 | Urease inhibitor | 0.193 0.011 DBMET00251 | DBMET00251 | |
| 0.2 | 0.036 | 0.2 | Insulin secretagoues | 0.199 0.036 DBMET00251 | ||
| 0.171 | 0.011 | 0.239 | HIV-1 integrase (Strand Transfer) inhibitor | 0.239 0.007 DBMET00251 | DBMET00251 | |
| 0.161 | 0.002 | 0.161 | Estrogen-related receptor beta antagonist | 0.155 0.002 DBMET00251 | ||
| 0.172 | 0.016 | 0.177 | Heat shock protein 70 antagonist | 0.177 0.013 DBMET00251 | DBMET00251 | |
| 0.305 | 0.153 | 0.305 | Calcium channel L-type activator | 0.235 0.222 DBMET00251 | ||
| 0.19 | 0.039 | 0.196 | Cyclooxygenase 1 inhibitor | 0.196 0.036 DBMET00251 | DBMET00251 | |
| 0.16 | 0.009 | 0.16 | Lipase inhibitor | 0.159 0.009 DBMET00251 | ||
| 0.165 | 0.014 | 0.165 | ABCA1 expression enhancer | 0.159 0.015 DBMET00251 | ||
| 0.169 | 0.018 | 0.17 | AMP-activated protein kinase stimulant | 0.17 0.018 DBMET00251 | DBMET00251 | |
| 0.171 | 0.021 | 0.171 | GABA C receptor antagonist | 0.143 0.034 DBMET00251 | ||
| 0.176 | 0.025 | 0.176 | Antineoplastic antibiotic | 0.171 0.026 DBMET00251 | ||
| 0.161 | 0.014 | 0.161 | CYP2A6 inhibitor | 0.126 0.024 DBMET00251 | ||
| 0.172 | 0.028 | 0.186 | Expectorant | 0.186 0.024 DBMET00251 | DBMET00251 | |
| 0.209 | 0.065 | 0.213 | Insulin sensitizer | 0.213 0.061 DBMET00251 | DBMET00251 | |
| 0.175 | 0.034 | 0.175 | Proteasome inhibitor | 0.173 0.035 DBMET00251 | ||
| 0.185 | 0.044 | 0.185 | Cyclin-dependent kinase 3 inhibitor | 0.172 0.058 DBMET00251 | ||
| 0.144 | 0.006 | 0.176 | Carbonic anhydrase VII inhibitor | 0.176 0.005 DBMET00251 | DBMET00251 | |
| 0.144 | 0.006 | 0.154 | D-Ala-D-Ala ligase inhibitor | 0.154 0.005 DBMET00251 | DBMET00251 | |
| 0.161 | 0.024 | 0.161 | Potassium channel (Ca-activated) activator | 0.123 0.039 DBMET00251 | ||
| 0.148 | 0.011 | 0.156 | Myeloperoxidase inhibitor | 0.156 0.01 DBMET00251 | DBMET00251 | |
| 0.144 | 0.007 | 0.154 | CDC25B inhibitor | 0.154 0.006 DBMET00251 | DBMET00251 | |
| 0.141 | 0.004 | 0.151 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.151 0.004 DBMET00251 | DBMET00251 | |
| 0.183 | 0.049 | 0.202 | Protein kinase stimulant | 0.202 0.041 DBMET00251 | DBMET00251 | |
| 0.147 | 0.015 | 0.158 | Keratolytic | 0.158 0.013 DBMET00251 | DBMET00251 | |
| 0.197 | 0.067 | 0.197 | 5 Hydroxytryptamine 3E antagonist | 0.188 0.086 DBMET00251 | ||
| 0.178 | 0.052 | 0.193 | Interferon gamma antagonist | 0.193 0.044 DBMET00251 | DBMET00251 | |
| 0.17 | 0.045 | 0.17 | Alpha-N-acetylglucosaminidase inhibitor | 0.131 0.068 DBMET00251 | ||
| 0.163 | 0.038 | 0.174 | Cholesterol synthesis inhibitor | 0.174 0.034 DBMET00251 | DBMET00251 | |
| 0.131 | 0.008 | 0.133 | Neuraminidase inhibitor | 0.133 0.008 DBMET00251 | DBMET00251 | |
| 0.175 | 0.053 | 0.178 | Cyclooxygenase inhibitor | 0.178 0.051 DBMET00251 | DBMET00251 | |
| 0.2 | 0.08 | 0.2 | Psychostimulant | 0.186 0.088 DBMET00251 | ||
| 0.245 | 0.127 | 0.245 | Thyroid hormone antagonist | 0.242 0.129 DBMET00251 | ||
| 0.223 | 0.105 | 0.234 | 5 Hydroxytryptamine 1E antagonist | 0.234 0.092 DBMET00251 | DBMET00251 | |
| 0.128 | 0.012 | 0.182 | Alpha tubulin antagonist | 0.182 0.007 DBMET00251 | DBMET00251 | |
| 0.132 | 0.018 | 0.132 | Cyclin B3 inhibitor | 0.132 0.018 DBMET00251 | ||
| 0.124 | 0.011 | 0.139 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.139 0.008 DBMET00251 | DBMET00251 | |
| 0.193 | 0.08 | 0.193 | Histone acetyltransferase inhibitor | 0.193 0.08 DBMET00251 | ||
| 0.214 | 0.103 | 0.214 | DNA synthesis inhibitor | 0.186 0.144 DBMET00251 | ||
| 0.123 | 0.014 | 0.123 | Alcohol oxidase inhibitor | 0.08 0.024 DBMET00251 | ||
| 0.172 | 0.063 | 0.179 | Arachidonic acid antagonist | 0.179 0.055 DBMET00251 | DBMET00251 | |
| 0.131 | 0.024 | 0.131 | Thioredoxin inhibitor | 0.128 0.026 DBMET00251 | ||
| 0.15 | 0.043 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 DBMET00251 | ||
| 0.133 | 0.028 | 0.133 | Anabolic | 0.131 0.03 DBMET00251 | ||
| 0.116 | 0.013 | 0.12 | Phosphodiesterase VI inhibitor | 0.12 0.012 DBMET00251 | DBMET00251 | |
| 0.273 | 0.171 | 0.273 | Transcription factor inhibitor | 0.255 0.183 DBMET00251 | ||
| 0.115 | 0.013 | 0.118 | Neuraminidase (influenza) inhibitor | 0.118 0.012 DBMET00251 | DBMET00251 | |
| 0.135 | 0.035 | 0.135 | UDP-glucose 4-epimerase inhibitor | 0.108 0.053 DBMET00251 | ||
| 0.131 | 0.031 | 0.138 | Prolactin inhibitor | 0.138 0.027 DBMET00251 | DBMET00251 | |
| 0.147 | 0.048 | 0.15 | Alkylator | 0.15 0.047 DBMET00251 | DBMET00251 | |
| 0.116 | 0.018 | 0.116 | Potassium channel large-conductance Ca-activated activator | 0.084 0.032 DBMET00251 | ||
| 0.116 | 0.02 | 0.137 | CDC25A inhibitor | 0.137 0.015 DBMET00251 | DBMET00251 | |
| 0.146 | 0.052 | 0.156 | Cyclooxygenase 3 inhibitor | 0.156 0.043 DBMET00251 | DBMET00251 | |
| 0.113 | 0.018 | 0.132 | HIV-1 integrase inhibitor | 0.132 0.012 DBMET00251 | DBMET00251 | |
| 0.113 | 0.019 | 0.161 | Beta tubulin antagonist | 0.161 0.011 DBMET00251 | DBMET00251 | |
| 0.123 | 0.032 | 0.126 | Androgen antagonist | 0.126 0.03 DBMET00251 | DBMET00251 | |
| 0.163 | 0.073 | 0.163 | Neurotensin receptor agonist | 0.154 0.092 DBMET00251 | ||
| 0.177 | 0.089 | 0.19 | Non-steroidal antiinflammatory agent | 0.19 0.079 DBMET00251 | DBMET00251 | |
| 0.166 | 0.079 | 0.166 | 3C-like protease (Human coronavirus) inhibitor | 0.144 0.111 DBMET00251 | ||
| 0.13 | 0.044 | 0.13 | Transcription factor STAT6 inhibitor | 0.127 0.048 DBMET00251 | ||
| 0.093 | 0.009 | 0.102 | Transcription factor RelA inhibitor | 0.102 0.006 DBMET00251 | DBMET00251 | |
| 0.132 | 0.048 | 0.137 | Interleukin 8 antagonist | 0.137 0.043 DBMET00251 | DBMET00251 | |
| 0.106 | 0.023 | 0.114 | Leukotriene synthesis inhibitor | 0.114 0.019 DBMET00251 | DBMET00251 | |
| 0.154 | 0.074 | 0.158 | Diuretic | 0.158 0.071 DBMET00251 | DBMET00251 | |
| 0.106 | 0.026 | 0.106 | Glutamate decarboxylase inhibitor | 0.105 0.027 DBMET00251 | ||
| 0.089 | 0.01 | 0.099 | CD45 antagonist | 0.099 0.009 DBMET00251 | DBMET00251 | |
| 0.092 | 0.017 | 0.092 | Aryl hydrocarbon receptor antagonist | 0.084 0.023 DBMET00251 | ||
| 0.184 | 0.11 | 0.216 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.216 0.091 DBMET00251 | DBMET00251 | |
| 0.101 | 0.027 | 0.101 | GABA aminotransferase inhibitor | 0.091 0.035 DBMET00251 | ||
| 0.08 | 0.007 | 0.08 | Cholesterol esterase inhibitor | 0.076 0.008 DBMET00251 | ||
| 0.101 | 0.028 | 0.101 | Thioredoxin reductase inhibitor | 0.097 0.032 DBMET00251 | ||
| 0.148 | 0.076 | 0.149 | Phospholipase A2 inhibitor | 0.149 0.076 DBMET00251 | DBMET00251 | |
| 0.102 | 0.03 | 0.102 | Na+ K+ transporting ATPase inhibitor | 0.1 0.031 DBMET00251 | ||
| 0.125 | 0.055 | 0.135 | DNA intercalator | 0.135 0.05 DBMET00251 | DBMET00251 | |
| 0.099 | 0.029 | 0.106 | Histone deacetylase stimulant | 0.106 0.024 DBMET00251 | DBMET00251 | |
| 0.099 | 0.029 | 0.106 | Histone deacetylase SIRT1 stimulant | 0.106 0.024 DBMET00251 | DBMET00251 | |
| 0.123 | 0.054 | 0.123 | TRPA1 agonist | 0.122 0.056 DBMET00251 | ||
| 0.138 | 0.069 | 0.142 | Farnesoid X receptor antagonist | 0.142 0.063 DBMET00251 | DBMET00251 | |
| 0.088 | 0.019 | 0.088 | Glutamate (mGluR7) antagonist | 0.08 0.028 DBMET00251 | ||
| 0.131 | 0.065 | 0.131 | CC chemokine 6 receptor antagonist | 0.123 0.103 DBMET00251 | ||
| 0.082 | 0.018 | 0.085 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.085 0.016 DBMET00251 | DBMET00251 | |
| 0.072 | 0.009 | 0.072 | Estrogen-related receptor alpha antagonist | 0.066 0.01 DBMET00251 | ||
| 0.118 | 0.056 | 0.124 | Mucolytic | 0.124 0.051 DBMET00251 | DBMET00251 | |
| 0.122 | 0.061 | 0.137 | Protein kinase (CK2) alpha inhibitor | 0.137 0.05 DBMET00251 | DBMET00251 | |
| 0.11 | 0.049 | 0.11 | Sphingomyelinase inhibitor | 0.087 0.077 DBMET00251 | ||
| 0.183 | 0.123 | 0.187 | Peptidyltransferase inhibitor | 0.187 0.117 DBMET00251 | DBMET00251 | |
| 0.212 | 0.154 | 0.212 | Cholesterol antagonist | 0.205 0.16 DBMET00251 | ||
| 0.07 | 0.015 | 0.07 | Potassium channel Kv1.3 blocker | 0.052 0.027 DBMET00251 | ||
| 0.08 | 0.025 | 0.08 | Carbonic anhydrase XII inhibitor | 0.08 0.025 DBMET00251 | ||
| 0.059 | 0.005 | 0.061 | ATP citrate lysase inhibitor | 0.061 0.005 DBMET00251 | DBMET00251 | |
| 0.126 | 0.074 | 0.131 | Cyclooxygenase 2 inhibitor | 0.131 0.069 DBMET00251 | DBMET00251 | |
| 0.1 | 0.048 | 0.1 | Triose-phosphate isomerase inhibitor | 0.082 0.073 DBMET00251 | ||
| 0.085 | 0.033 | 0.089 | Carbonic anhydrase VA inhibitor | 0.089 0.031 DBMET00251 | DBMET00251 | |
| 0.092 | 0.04 | 0.092 | Porphobilinogen synthase inhibitor | |||
| 0.072 | 0.02 | 0.072 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.068 0.023 DBMET00251 | ||
| 0.137 | 0.086 | 0.147 | Adenylate cyclase stimulant | 0.147 0.068 DBMET00251 | DBMET00251 | |
| 0.077 | 0.026 | 0.077 | Androgen agonist | 0.073 0.028 DBMET00251 | ||
| 0.109 | 0.059 | 0.109 | Mediator release inhibitor | 0.109 0.06 DBMET00251 | ||
| 0.073 | 0.026 | 0.076 | Carbonic anhydrase VB inhibitor | 0.076 0.024 DBMET00251 | DBMET00251 | |
| 0.057 | 0.011 | 0.057 | DNA gyrase subunit A inhibitor | 0.051 0.016 DBMET00251 | ||
| 0.22 | 0.176 | 0.225 | Immunosuppressant | 0.225 0.171 DBMET00251 | DBMET00251 | |
| 0.075 | 0.03 | 0.075 | Adenosine A1 receptor antagonist | 0.059 0.04 DBMET00251 | ||
| 0.063 | 0.019 | 0.063 | CXC chemokine 1 receptor antagonist | 0.058 0.024 DBMET00251 | ||
| 0.079 | 0.036 | 0.084 | Carbonic anhydrase V inhibitor | 0.084 0.034 DBMET00251 | DBMET00251 | |
| 0.118 | 0.076 | 0.118 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.07 | 0.028 | 0.078 | Heat shock protein 90 beta antagonist | 0.078 0.022 DBMET00251 | DBMET00251 | |
| 0.055 | 0.014 | 0.068 | Dopamine D5 agonist | 0.068 0.009 DBMET00251 | DBMET00251 | |
| 0.196 | 0.157 | 0.196 | Thyroid hormone beta antagonist | 0.193 0.16 DBMET00251 | ||
| 0.046 | 0.007 | 0.046 | Sodium/glucose cotransporter 2 inhibitor | 0.035 0.01 DBMET00251 | ||
| 0.103 | 0.065 | 0.108 | Toll-Like receptor 4 antagonist | 0.108 0.058 DBMET00251 | DBMET00251 | |
| 0.179 | 0.142 | 0.179 | 5 Hydroxytryptamine release stimulant | 0.163 0.162 DBMET00251 | ||
| 0.091 | 0.055 | 0.091 | Ornithine decarboxylase inhibitor | 0.09 0.056 DBMET00251 | ||
| 0.099 | 0.065 | 0.109 | Protein kinase (CK2) inhibitor | 0.109 0.056 DBMET00251 | DBMET00251 | |
| 0.08 | 0.046 | 0.08 | MAP kinase kinase 7 inhibitor | 0.079 0.049 DBMET00251 | ||
| 0.202 | 0.168 | 0.237 | Angiogenesis inhibitor | 0.237 0.133 DBMET00251 | DBMET00251 | |
| 0.09 | 0.056 | 0.09 | NADH dehydrogenase inhibitor | 0.082 0.071 DBMET00251 | ||
| 0.065 | 0.031 | 0.065 | Sphingosine kinase inhibitor | 0.064 0.032 DBMET00251 | ||
| 0.11 | 0.077 | 0.154 | DNA polymerase I inhibitor | 0.154 0.047 DBMET00251 | DBMET00251 | |
| 0.049 | 0.017 | 0.049 | Kinesin-like protein 1 inhibitor | 0.042 0.02 DBMET00251 | ||
| 0.049 | 0.017 | 0.049 | Kinesin antagonist | 0.042 0.02 DBMET00251 | ||
| 0.088 | 0.056 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | 0.097 0.039 DBMET00251 | DBMET00251 | |
| 0.054 | 0.024 | 0.054 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.035 DBMET00251 | ||
| 0.129 | 0.1 | 0.157 | Thrombolytic | 0.157 0.076 DBMET00251 | DBMET00251 | |
| 0.084 | 0.055 | 0.084 | Estrogen-related receptor beta agonist | 0.079 0.07 DBMET00251 | ||
| 0.098 | 0.069 | 0.098 | GABA C receptor agonist | |||
| 0.055 | 0.026 | 0.068 | Topoisomerase II beta inhibitor | 0.068 0.017 DBMET00251 | DBMET00251 | |
| 0.038 | 0.01 | 0.038 | Protein 30S ribosomal subunit inhibitor | 0.033 0.012 DBMET00251 | ||
| 0.066 | 0.038 | 0.067 | Nitric oxide donor | 0.067 0.037 DBMET00251 | DBMET00251 | |
| 0.115 | 0.088 | 0.117 | Glycogen synthase kinase-3 alpha inhibitor | 0.117 0.087 DBMET00251 | DBMET00251 | |
| 0.066 | 0.039 | 0.066 | Adenosine A2a receptor antagonist | |||
| 0.118 | 0.093 | 0.122 | Vanilloid 1 agonist | 0.122 0.083 DBMET00251 | DBMET00251 | |
| 0.058 | 0.033 | 0.058 | Dihydroorotate oxidase inhibitor | 0.055 0.039 DBMET00251 | ||
| 0.118 | 0.093 | 0.118 | Histone deacetylase SIRT1 inhibitor | 0.115 0.098 DBMET00251 | ||
| 0.033 | 0.009 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 DBMET00251 | ||
| 0.089 | 0.066 | 0.092 | HIV-1 integrase (Overall Integration) inhibitor | 0.092 0.063 DBMET00251 | DBMET00251 | |
| 0.071 | 0.047 | 0.071 | Phosphofructokinase-1 inhibitor | |||
| 0.07 | 0.049 | 0.07 | Peroxisome proliferator-activated receptor gamma agonist | 0.069 0.05 DBMET00251 | ||
| 0.146 | 0.125 | 0.227 | Antimitotic | 0.227 0.07 DBMET00251 | DBMET00251 | |
| 0.111 | 0.09 | 0.149 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.149 0.062 DBMET00251 | DBMET00251 | |
| 0.045 | 0.025 | 0.045 | GABA B receptor antagonist | 0.042 0.031 DBMET00251 | ||
| 0.037 | 0.017 | 0.076 | Catechol O-methyltransferase inhibitor | 0.076 0.005 DBMET00251 | DBMET00251 | |
| 0.061 | 0.042 | 0.061 | Purinergic P2X1 antagonist | |||
| 0.072 | 0.054 | 0.072 | Adenosine A3 receptor antagonist | |||
| 0.054 | 0.037 | 0.055 | Leukotriene B4 antagonist | 0.055 0.035 DBMET00251 | DBMET00251 | |
| 0.027 | 0.012 | 0.03 | Estrone sulfatase inhibitor | 0.03 0.01 DBMET00251 | DBMET00251 | |
| 0.062 | 0.048 | 0.062 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.018 | 0.005 | 0.018 | Antibiotic Tetracycline-like | 0.017 0.006 DBMET00251 | ||
| 0.034 | 0.021 | 0.035 | Protein kinase (CK2) beta inhibitor | 0.035 0.018 DBMET00251 | DBMET00251 | |
| 0.07 | 0.057 | 0.07 | Glutamate dehydrogenase inhibitor | |||
| 0.092 | 0.079 | 0.092 | Hedgehog signaling inhibitor | |||
| 0.058 | 0.045 | 0.058 | Cyclin D1 inhibitor | |||
| 0.065 | 0.052 | 0.065 | Phenylalanine 4-hydroxylase inhibitor | 0.064 0.053 DBMET00251 | ||
| 0.053 | 0.04 | 0.054 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.054 0.039 DBMET00251 | DBMET00251 | |
| 0.089 | 0.077 | 0.092 | Phosphodiesterase 6D inhibitor | 0.092 0.069 DBMET00251 | DBMET00251 | |
| 0.247 | 0.236 | 0.271 | MAP kinase 1 inhibitor | 0.271 0.211 DBMET00251 | DBMET00251 | |
| 0.034 | 0.024 | 0.034 | Calcitonin receptor agonist | |||
| 0.032 | 0.023 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 DBMET00251 | ||
| 0.023 | 0.015 | 0.038 | Dopamine D1 agonist | 0.038 0.006 DBMET00251 | DBMET00251 | |
| 0.058 | 0.05 | 0.058 | Adenosine A2 receptor antagonist | |||
| 0.038 | 0.031 | 0.04 | DNA-dependent protein kinase inhibitor | 0.04 0.029 DBMET00251 | DBMET00251 | |
| 0.044 | 0.036 | 0.044 | Purinergic P2X4 antagonist | 0.043 0.037 DBMET00251 | ||
| 0.019 | 0.012 | 0.019 | Antibiotic Anthracycline-like | |||
| 0.129 | 0.124 | 0.129 | Antipruritic | |||
| 0.091 | 0.086 | 0.091 | Adenylate kinase inhibitor | |||
| 0.022 | 0.018 | 0.022 | Dopamine autoreceptor agonist | |||
| 0.05 | 0.046 | 0.05 | Cyclin B inhibitor | 0.049 0.048 DBMET00251 | ||
| 0.057 | 0.054 | 0.059 | Heme oxygenase stimulant | 0.059 0.048 DBMET00251 | DBMET00251 | |
| 0.064 | 0.062 | 0.064 | Cathepsin G inhibitor | |||
| 0.096 | 0.093 | 0.097 | Electron transport complex I inhibitor | 0.097 0.089 DBMET00251 | DBMET00251 | |
| 0.032 | 0.03 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET00251 | DBMET00251 | |
| 0.099 | 0.097 | 0.099 | MAP kinase kinase inhibitor | |||
| 0.046 | 0.048 | 0.047 | Factor III inhibitor | 0.047 0.042 DBMET00251 | DBMET00251 | |
| 0.022 | 0.026 | 0.024 | Thyroid hormone agonist | 0.024 0.023 DBMET00251 | DBMET00251 | |
| 0.081 | 0.085 | 0.098 | Bronchodilator | 0.098 0.066 DBMET00251 | DBMET00251 | |
| 0.041 | 0.046 | 0.048 | Carbonic anhydrase XIV inhibitor | 0.048 0.035 DBMET00251 | DBMET00251 | |
| 0.044 | 0.05 | 0.049 | Squalene epoxidase inhibitor | 0.049 0.037 DBMET00251 | DBMET00251 | |
| 0.045 | 0.052 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.032 DBMET00251 | DBMET00251 | |
| 0.113 | 0.129 | 0.12 | Hemostatic | 0.12 0.113 DBMET00251 | DBMET00251 | |
| 0.121 | 0.143 | 0.133 | Tumour necrosis factor antagonist | 0.133 0.123 DBMET00251 | DBMET00251 | |
| 0.044 | 0.079 | 0.057 | Dopamine D1 antagonist | 0.057 0.054 DBMET00251 | DBMET00251 | |
| 0.035 | 0.098 | 0.066 | Dopamine agonist | 0.066 0.047 DBMET00251 | DBMET00251 | |
| 0.112 | 0.226 | 0.143 | Death-associated protein kinase 2 inhibitor | 0.143 0.124 DBMET00251 | DBMET00251 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |